Barely Significant
← all excerpts

The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer.

Cancers (Basel) · 2024 · PMC11274797 · PMID 39061205

Europe PMCDOI
1
hedged sentence
0.0019
closest p · 0.0× alpha
0.0019
boldest claim

The sentences

markedly significantp = 0.0019actually significant
The HER2-low group demonstrated superior outcomes for DFS ( p = 0.0130), DMFS ( p = 0.0300), OS ( p = 0.0120), and particularly for BCSS, which showed a markedly significant difference ( p = 0.0019) ( Figure 4 ). 3.3.

also in 412 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.